Navigation Links
Two Cases in U.S raise alarm of an unusual strain of Mad Cow Disease.

Washington: Two cases of a different and rather intriguing strain of mad cow disease has been detected in Texas and Alabama, and this has led researchers //to believe that this disease could affect the cattle without any prior warning.

The underlying differences between the mad cow epidemic and the two U.S. cases are intriguing researchers who are unable to place a finger on the type of brain disorder. Remedial measures and available treatment is being meted out to contain the disease.


'"/>




Page: 1

Related medicine news :

1. China reports declining number of SARS Cases
2. Dengue in Delhi – 26 Cases reported and 3 dea
3. Dengue Epidemic in West Bengal: Over 1000 New Cases and 15 dead
4. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
5. Plump Infants Getting Obese Later In Life In More Cases
6. Only 30 Polio Cases Reported In India
7. Human Bird Flu Cases Total 130: WHO
8. Three More Bird Flu Cases Reported By China
9. AIDS Cases On The Rise In West Bengal
10. WBSACS Says Number Of AIDS Cases On The Rise
11. Pakistan On Alert After Cases Of Fatal Fever
Post Your Comments:
(Date:10/13/2008)...oreValve ( www.corevalve.com ) announced today tha...g System for percutaneous aortic valve replacement... continues to enroll patients at an accelerating p...d worldwide at nearly 100 centers in 20 countries....ess Wire EON) October 13, 2008 -- During the Mond...
(Date:10/13/2008).../PRNewswire/ -- Michael Merzenich, PhD.,co-founde...as been elected,to the Institute of Medicine accor.... Merzenich is one of 65 newly elected members., ...cess that recognizes,people who have made major co...nces, health care, and public health. Election is ...
(Date:10/13/2008)...othies Given Away, FORT WORTH, Texas, Oct. 13 /PR...e third annual FitFuture KIDS Fest at the Will Rog...facturing plant in Fort Worth, passed,out thousand...ated support,for a healthier Tarrant County. The p... KIDS Fest is to help educate families about their...
(Date:10/13/2008)...Newswire-USNewswire/ -- The 2008 NCPA Digest,spon...e NCPA 110th Annual,Convention. The Digest has bee...s the most comprehensive portrait of the financial...previous calendar year. Last year,s,Digest provide...cription,drug program had played a leading role in...
Breaking Medicine News(10 mins):Health News: CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008 2Health News:Merzenich Elected to Institute of Medicine 2Health News:Merzenich Elected to Institute of Medicine 3Health News:The Dannon Company Sponsors FitFuture KIDS Fest 2Health News:The Dannon Company Sponsors FitFuture KIDS Fest 3Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 2Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 3
...earchers at The University of Texas M. D. Anderson... plays a significant role in determining// the agg...ailed in the in the October 1 issue of Clinical Ca...of an earlier research that had linked obesity to ...
...a from the extension of a Phase II study to 12 mon...ovel oral medication//, for the treatment of patie...ata, presented at the ECTRIMS/ACTRIMS meeting in T...patient groups taking FTY720 (1.25 mg and 5 mg) wh...
...betes is a chronic illness that requires continuin...on to prevent acute complications and to reduce th...ence of diabetes continues to soar, primary care p...ng tide of patients presenting with signs of diabe...
...ew study has now confirmed an ancient myth that co...e finding that it contains certain chemicals that ...rrhea//. The use of cocoa to treat diarrhea dates ...ent South American and European cultures. Until no...
Other Medicine News:Health News:Novartis MS Drug Shows Promising Results 2Health News:Novartis MS Drug Shows Promising Results 3
(Date:10/12/2008)...N, Oct. 12 /- Boston,Scient...ults from an analysis,of nearly 7,500 patients fro...esigned to confirm the performance of the TAXUS(R)...stem in real-world practice. The,two-year pooled A...nical,restenosis in patients with diabetes as effe...
(Date:10/10/2008)...Newswire-FirstCall/ -- Inverness Medical,Innovatio...-patient,diagnostics, monitoring and health manage...e Secretary-General of the United Nations, as part...he world,s leading,research-based and generic phar...gether with senior officials from the United Natio...
(Date:10/9/2008)...s on the need to protect the eyesight of,older peo...illion people worldwide who,are blind, 80 percent ...have avoided their blindness if they had been prop...a News Release, go to:, http://www.prnewswire.com/...ye care products and equipment, is,partnering with...
(Date:10/9/2008)...swire-FirstCall/ -- Diamyd Medical reports,that th...w England Journal,of Medicine, has published an ar... Diamyd(R) diabetes vaccine for type 1 diabetes., ...314/297194 ), The article is now available on th...ill be in print on October 30. It presents the,res...
Breaking Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Alzheimers Treatment Trials May Have Special Challenges 24437 1Alzheimers Treatment Trials May Have Special Challenges 24437 2David Farhadi M D to Join Alger as Vice President Senior Analyst Co Portfolio Manager 6754 1David Farhadi M D to Join Alger as Vice President Senior Analyst Co Portfolio Manager 6754 2The kids most likely to go armed 24429 1The kids most likely to go armed 24429 2Pre eclampsia may be autoimmune disease 4220 1Pre eclampsia may be autoimmune disease 4220 2Pre eclampsia may be autoimmune disease 4220 3
...ire-FirstCall/ -- Celgene,Corporation announced th...as reported that its Data Monitoring Committee,s (...andomized clinical,trial for patients with newly d...f a low dose of dexamethasone (Decadron) in,combin...e for,patients when compared to the higher, standa...
...ire/ -- Novagali Pharma, an,emerging ophthalmic ph... announces today positive results from the Phase I...ing from Vernal,Keratoconjunctivitis (VKC). In thi...and signs of disease improved in patients,receivin...acia(R),was excellent. , VKC is a severe form of c...
Other Medicine Technology:ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 2ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 4ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 5ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
...lXpress™ kit provides a rapid method for the ...tent nucleic acids; however, the kit does not sepa...NA can be achieved by incubating the purified mate...lowed by re-extraction with ViralXpress™. The...
The Mago® Plus Automated EIA Analyzer is a fully automated, integrated ELISA system. Together, with immunosimplicity® reagents, the Mago® Plus provides a flexible, integrated solution
The Titertek MAP-C2 is designed for high throughput microplate processing. The heart of the instrument is the S60 Stacker that handles up to 60 microplates in two removable magazines. The MAP-C2 base
...imeter 4000 provides a fast, accurate assessment o...eters patented,state-of-the-art optics yield acc...moglobin as well as total hemoglobin. When,used ...imeter,4000 gives a comprehensive and complete a...
Medicine Products: